Cases 21 - 30 of 80
Boehringer Ingelheim Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Limited et al
as 1:2021cv01487
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. and Ohm Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2021cv01486
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al.
as 1:2021cv01485
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2021cv00530
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al
as 1:2021cv00356
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited,
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2020cv01585
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al
as 1:2020cv01153
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited,
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bell v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 1:2020cv00974
Plaintiff:
Hiheshia Bell
Defendant:
John Does 1-5, Sanofi US Services Inc., GlaxoSmithKline LLC and others
Cause Of Action: 28 U.S.C. § 1441
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00277
Defendant:
Annora Pharma Private Limited and Hetero USA Inc.,
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2019cv01885
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
